ArticlePDF AvailableLiterature Review

Diet for stroke prevention

Authors:
  • The University of Western Ontario, Robarts Research Institute

Abstract and Figures

Lifestyle is far more important than most physicians suppose. Dietary changes in China that have resulted from increased prosperity are probably responsible for a marked rise in coronary risk in the past several decades, accelerating in recent years. Intake of meat and eggs has increased, while intake of fruits, vegetables and whole grains has decreased. Between 2003 and 2013, coronary mortality in China increased 213%, while stroke mortality increased by 26.6%. Besides a high content of cholesterol, meat (particularly red meat) contains carnitine, while egg yolks contain phosphatidylcholine. Both are converted by the intestinal microbiome to trimethylamine, in turn oxidised in the liver to trimethylamine n-oxide (TMAO). TMAO causes atherosclerosis in animal models, and in patients referred for coronary angiography high levels after a test dose of two hard-boiled eggs predicted increased cardiovascular risk. The strongest evidence for dietary prevention of stroke and myocardial infarction is with the Mediterranean diet from Crete, a nearly vegetarian diet that is high in beneficial oils, whole grains, fruits, vegetables and legumes. Persons at risk of stroke should avoid egg yolk, limit intake of red meat and consume a diet similar to the Mediterranean diet. A crucial issue for stroke prevention in China is reduction of sodium intake. Dietary changes, although difficult to implement, represent an important opportunity to prevent stroke and have the potential to reverse the trend of increased cardiovascular risk in China.
Content may be subject to copyright.
44 SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
Diet for stroke prevention
J David Spence1,2
1Stroke Prevention &
Atherosclerosis Research
Centre, Robarts Research
Institute, London, Ontario,
Canada
2Neurology and Clinical
Pharmacology, University of
Western Ontario, London,
Ontario, Canada
Correspondence to
ProfessorJ DavidSpence;
dspence@ robarts. ca
To cite: SpenceJD. Diet for
stroke prevention. Stroke and
Vascular Neurology 2018;3:
e000130. doi:10.1136/svn-
2017-000130
Received 8 December 2017
Revised 29 December 2017
Accepted 29 December 2017
Published Online First
13January2018
http:// dx. doi. org/ 10. 1136/
svn- 2018- 000171
Review
ABSTRACT
Lifestyle is far more important than most physicians
suppose. Dietary changes in China that have resulted
from increased prosperity are probably responsible for a
marked rise in coronary risk in the past several decades,
accelerating in recent years. Intake of meat and eggs has
increased, while intake of fruits, vegetables and whole
grains has decreased. Between 2003 and 2013, coronary
mortality in China increased 213%, while stroke mortality
increased by 26.6%. Besides a high content of cholesterol,
meat (particularly red meat) contains carnitine, while egg
yolks contain phosphatidylcholine. Both are converted
by the intestinal microbiome to trimethylamine, in turn
oxidised in the liver to trimethylamine n-oxide (TMAO).
TMAO causes atherosclerosis in animal models, and in
patients referred for coronary angiography high levels after
a test dose of two hard-boiled eggs predicted increased
cardiovascular risk. The strongest evidence for dietary
prevention of stroke and myocardial infarction is with
the Mediterranean diet from Crete, a nearly vegetarian
diet that is high in beneficial oils, whole grains, fruits,
vegetables and legumes. Persons at risk of stroke should
avoid egg yolk, limit intake of red meat and consume a
diet similar to the Mediterranean diet. A crucial issue for
stroke prevention in China is reduction of sodium intake.
Dietary changes, although difficult to implement, represent
an important opportunity to prevent stroke and have the
potential to reverse the trend of increased cardiovascular
risk in China.
When ranked in order of importance, among
the interventions available to prevent stroke,
the three most important are probably
diet, smoking cessation and blood pressure
control.1 Hypertension and smoking cessa-
tion are discussed in other papers in this issue
of the journal. In this paper I discuss diet and
stroke prevention.
IMPORTANCE OF LIFESTYLE
Lifestyle is much more important than
most physicians suppose. In the US Health
Professionals study and the Nurses’ Health
Study, poor lifestyle choices accounted for
more than half of stroke.2 Participants who
achieved all five healthy lifestyle choices—not
smoking, moderate intake of alcohol, a body
mass index <25, daily exercise for 30 min and
a healthy diet score in the top 40%—had
an 80% reduction of stroke compared with
participants who achieved none. In a study
in Swedish women, all five choices reduced
the risk of stroke by 60%.3 Among Swedish
men with hypertension and dyslipidaemia,
all five healthy behaviours reduced coronary
events by more than 80%.4
HARMFUL DIETARY TRENDS
In the USA, the worst of the lifestyle choices
is diet. The American Heart Association statis-
tical report of 2015 indicated that only 0.1% of
Americans consumed a healthy diet and only
8.3% consumed a moderately healthy diet.5
In China, the consumption of meat and eggs
has increased markedly in recent years, while
consumption of whole grains, vegetables and
fruit has declined.6 This probably accounts
for much of the increase in fasting cholesterol
levels7 and in coronary disease6 8 in China at
the same time. Stroke is much more common
than myocardial infarction in China, and in
the past most strokes were due to hyperten-
sion. What has happened in China is that
myocardial infarctions have increased mark-
edly, with a much smaller increase in stroke.
Between 2003 and 2013, stroke mortality per
100 000 in urban people increased from 102.44
to 125.56 (a 26.6% increase), while coronary
mortality increased from 16.46/100 000 urban
people to 51.46/100 000 (a 213% increase)6
(figure 1). Undoubtedly strokes due to large
artery disease in China will have increased
in proportion during that time, the opposite
of what was seen in a Canadian stroke clinic
population between 2002 and 2012.9
TRENDS IN DIETARY GUIDELINES
In the past, a low-fat diet was recommended
to reduce cardiovascular risk; however, as
pointed out by Willett and Stampfer,10 the
low-fat diet was essentially ‘pulled from thin
air’ by a committee trying to imagine a diet
that would lower fasting levels of low-density
lipoprotein (LDL) cholesterol. Recent dietary
guidelines tend to recommend a dietary
pattern, rather than specifying limits to intake
of particular foods or nutrients. Increasingly,
guidelines are recommending reduction
of intake of animal fat and increased intake
of fruits and vegetables—a more plant-
based diet. The Dietary Approaches to Stop
Hypertension (DASH) diet11 emphasised
fruits, vegetables and low-fat dairy foods with
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
45
SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
reduced intake of saturated fat, total fat and cholesterol;
it included whole grains, poultry, fish and nuts, and was
reduced in red meat, sweets and sugar-containing bever-
ages. This appears to be similar to the Mediterranean diet,
but there are important differences: the Mediterranean
diet also emphasises whole grains, fruits and vegetables,
but it is high in beneficial oils (olive and canola), low in
dairy products and contains much less animal flesh. In a
retrospective article,12 Ancel Keys, the leader of the Seven
Countries Study, described it as follows: ‘The heart of this
diet is mainly vegetarian, and differs from American and
northern European diets in that it is much lower in meat
and dairy products and uses fruit for dessert’.
EVIDENCE FOR THE MEDITERRANEAN DIET
The diet with the best evidence for stroke prevention is
the Mediterranean diet from Crete. In the Seven Coun-
tries Study, it was discovered that coronary risk in Crete
was 1/15th that in Finland and only 40% of that in
Japan.10 In a retrospective article, Ancel Keys described
it as ‘a mainly vegetarian diet…favoring fruit for dessert’.
The diet is not a low-fat diet; it is a low glycaemic/high-fat
diet with 40% of calories from beneficial fats such as olive
and canola oil, and high in whole grains, fruits, vegeta-
bles and legumes (peas, lentils, beans, nuts and so on)
(figure 2).
n secondary prevention, in the Lyon Diet Heart Study,13
the Mediterranean diet was approximately twice as effi-
cacious as was simvastatin in the contemporaneous Scan-
dinavian Simvastatin Survival Study (4S).14 Both studies
enrolled patients who had survived a myocardial infarc-
tion; in the Lyon Diet Heart Study, the Mediterranean
diet reduced coronary events and stroke by more than
70% in 4 years; in the 4S trial, simvastatin reduced recur-
rent coronary events by 40% in 6 years. In primary preven-
tion, in the Spanish Primary Prevention of Cardiovascular
Disease with a Mediterranean Diet (PREDIMED) study,15
a low-fat diet was compared with two Mediterranean diet
arms: one fortified with olive oil, while the other fortified
with mixed nuts. Both versions of the Mediterranean diet
significantly reduced cardiovascular events; the nut-forti-
fied version reduced stroke by 47% in 5 years.
PROBLEMS WITH LOW-FAT DIETS
In recent years there has been much said about how the
dietary villain is not cholesterol and egg yolk but sugar,
and some have mistakenly blamed the Mediterranean diet
for the low-fat diet that has resulted in a marked increase
in carbohydrate intake, with increases in diabetes and
obesity.16 However, the low-fat diet did not result from
Figure 1 Trends in cardiovascular mortality in China, 2003–
2013. (A) Increase in mortality from myocardial infarction and
(B) increase in mortality from stroke. Myocardial infarction
increased much more steeply than stroke, probably in
large part because of changes in diet in China over time
with increased prosperity. Strokes in China are largely due
to hypertension, whereas myocardial infarctions are more
closely related to intake of meat and egg yolk. (Reproduced
with permission from the European Heart Journal, Weiwei et
al.6)
Figure 2 The Mediterranean diet. The Mediterranean diet
is a high-fat/lowglycaemic diet with 40% of calories from
fat; however, the fat is mainly benecial oils such as olive
and canola. Among men in the Seven Countries Study, the
coronary risk in Crete was only 1/15th of that in Finland,
where most of the fat was saturated fat (accompanied by
cholesterol), and 40% of that in Japan, where the diet is
a low-fat diet favouring sh.(Reproduced from Willet and
Stampfer.10)
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
46 SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
the discovery of the Mediterranean diet. With its high fat
content (40% of calories from fat, mainly olive oil)10 and
emphasis on whole grains, the Mediterranean diet is actu-
ally a low glycaemic diet.
The result of this discussion has been a widespread and
popular, but entirely mistaken, move to increased use of
low-carbohydrate (low-carb) diets, with a high intake of
cholesterol and animal fat. This is disastrous, and to a
great extent due to propaganda of the food industry.17
Like the sugar industry18 the meat and egg industries
spend hundreds of millions of dollars on propaganda,
unfortunately with great success.19–21 Box 1 provides links
to information about this issue.
An Israeli diet study22 provided perhaps the best
evidence that the Cretan Mediterranean diet is actu-
ally better than a low-carb diet for diabetes and insulin
resistance. Overweight residents in an institution, who
obtained their meals from the cafeteria, were randomised
to a low-fat diet, a low-carb diet or the Mediterranean
diet. Adherence was 95% at 1 year and 86% at 2 years,
unusually good for dietary studies. Weight loss was iden-
tical on the low-carb and Mediterranean diet, and both
were significantly better than the low-fat diet. Among
participants with diabetes, fasting glucose, fasting insulin
levels and insulin resistance were clearly the best on the
Mediterranean diet.22
Propaganda of the egg industry and the red meat industry
Following an exposé of the propaganda of the sugar
industry in which the ‘smoking gun’ was unearthed in
archives,18 Nestle17 commented on the attempts of the
food industry in general to influence public beliefs. I
commented on the egg industry and the meat industry.19
The two pillars of the egg industry propaganda are
a red herring and a half-truth. The red herring is a
misplaced focus on the effects of diet on fasting lipids.
Diet is not about the fasting state; it is about the postpran-
dial state.23 24 For ~4 hours after a high-fat/high-choles-
terol meal, there is marked oxidative stress, endothelial
dysfunction and arterial inflammation.25
The half-truth is the slogan ‘eggs can be part of a healthy
diet for healthy people’. This is based on two US studies
that did not find harm from egg consumption except
among participants who became diabetic, in whom an
egg a day ‘only’ doubled coronary risk.26 27 However, as
discussed above, the US diet is so bad that it is difficult to
show harm from any component (figure 3). In Greece,
however, where the Mediterranean diet is the norm, an
egg a day increased coronary risk fivefold among persons
with diabetes, and even 10 g per day of egg (a sixth of
a large egg) increased coronary risk by 54%.28 Egg
consumption also increases the risk of diabetes.29
The 2016 US guideline
In 2016, when the new US dietary guideline was released,
there were headlines trumpeting ‘It’s OK to eat choles-
terol again; the new guideline says so’. But it was not
true. In the first paragraph, the press release said that
there were insufficient data to recommend a specific
limit to cholesterol intake, as in the past (300 mg/day
for healthy people or 200 mg/day for those at risk of
vascular disease).30 However, the second paragraph said:
‘However, cholesterol intake should be as low as possible
within the recommended eating pattern’ (which resem-
bles a Mediterranean diet). The paragraphs should have
been reversed. There are still good reasons to recom-
mend a cholesterol intake below 200 mg/day (less than
one large egg yolk), and other guidelines do so.31
It is little understood that ‘people at risk of vascular
disease’ essentially means everyone who aspires to achieve
a healthy old age.32 A 20-year-old man might think he can
eat eggs and smoke with impunity, because his stroke or
myocardial infarction are 45 years in the future. But why
would he want to bring it on sooner?33
Effects of the intestinal microbiome
Although dietary cholesterol does not increase fasting
lipid levels by much, it clearly does increase coronary
mortality.34 35 However, there is increasing recognition
of the importance of the intestinal microbiome.36 While
cholesterol content is essentially the same for any kind of
animal flesh, red meat has more saturated fat, and has ~4
times as much carnitine as chicken or fish. Carnitine from
red meat37 and phosphatidylcholine from egg yolk37 are
converted by the intestinal bacteria to trimethylamine,
in turn oxidised in the liver to trimethylamine n-oxide
(TMAO) (figure 4). TMAO causes atherosclerosis in
animal models,37 and in patients undergoing coronary
angiograms plasma levels in the top quartile of TMAO
levels after a test dose of two hard-boiled eggs predicted
a 2.5-fold increase in the 3-year risk of stroke, myocar-
dial infarction or vascular death.38 A 12-ounce Hardee’s
Monster Thickburger39 contains 265 mg of cholesterol
and 320 mg of carnitine. The yolk of a 65 g egg contains
237 mg of cholesterol and 250 mg of carnitine, so two egg
yolks are worse than the 12-ounce burger. Patients at risk
of stroke should avoid red meat and egg yolk.
Besides TMAO, there are other toxic metabolites
produced by the intestinal bacteria from amino acids,
including P-cresyl sulfate, hippuric acid, indoxyl sulfate,
P-cresyl glucuronide, phenyl acetyl glutamine and phenyl
sulfate. These toxic metabolites of the intestinal micro-
biome are renally excreted, so they may be termed
‘Gut-derived Uremic Toxins’ (GDUT). Their blood levels
are very high in patients with renal failure. Other uraemic
Box 1 Links to videos about egg industry propaganda
http://nutritionfacts.org/video/
eggs-and-cholesterol-patently-false-and-misleading-claims/.
http://nutritionfacts.org/video/
eggs-vs-cigarettes-in-atherosclerosis/.
http://nutritionfacts.org/video/egg-cholesterol-in-the-diet/.
http://nutritionfacts.org/video/
how-the-egg-board-designs-misleading-studies/.
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
47
SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
toxins that have high plasma levels in renal failure are
thiocyanate, asymmetric dimethylarginine and homocys-
teine. Homocysteine accounts for only ~20% of the effect
of renal impairment on carotid plaque burden40; we
hypothesised40 that GDUT may account for much of the
very high risk associated with renal failure.41 Renal func-
tion declines linearly with age, and by age 80 the average
estimated glomerular filtration rate in patients attending
Figure 3 Diet is the worst of the risk issues in the USA. Prevalence (unadjusted) estimates for poor, intermediate and ideal
cardiovascular health for each of the sevenmetrics of cardiovascular health in the American Heart Association 2020 goals, US
children aged 12–19 years, National Health and Nutrition Examination Survey (NHANES) 2011–2012. *Healthy diet score data
reect 2009–2010 NHANES data.(Reproduced with permission from Wolters Kluwer, Mozaffarian etal.5)
Figure 4 Trimethylamine n-oxide(TMAO) is produced by the intestinal bacteria from phosphatidylcholine. Carnitine (largely
from red meat) and phosphatidylcholine (largely from egg yolk) are converted by the intestinal bacteria to trimethylamine, which
in turn is oxidised by the liver to TMAO. TMAO causes atherosclerosis in animal models and markedly increases the risk of
stroke, myocardial infarction and cardiovascular mortality, particularly in persons with renal impairment. It also accelerates
decline of renal function. (Permission requested to reproduce from Wangetal.58) FMO, avin-containing monooxygenase.
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
48 SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
a stroke prevention clinic is below 60 mL/min/1.73 m2.40
We have evidence that even moderate renal impair-
ment significantly increases plasma levels of the GDUT
(submitted for publication). This means that persons
with renal impairment, including most elderly patients,
should avoid red meat and egg yolk.
COFFEE AND TEA
The role of regular consumption of tea or coffee on
cardiovascular risk has not been tested in randomised
controlled trials. There is moderately good evidence that
consumption of coffee and tea reduces risk of myocar-
dial infarction, but little mention of stroke in that body
of literature. It seems likely that reduction of myocardial
infarction would be associated with reduction of stroke
risk.
Coffee consumption has been controversial for many
years. An early report from the Framingham Study indi-
cated that tea, but not coffee, reduced the risk of myocar-
dial infarction.42 For both tea and coffee there are two
issues to be considered: the effects of caffeine and the
effects of antioxidants. Some evidence that caffeine in
coffee may be harmful came from a study in which slow
metabolisers of caffeine (because of a variant of the
CYP1A2 genotype) appeared to have increased the risk of
myocardial infarction.43 A recent meta-analysis indicates
that consuming 3–5 cups per day of coffee reduces cardio-
vascular risk.44 As both decaffeinated and regular coffee
appear to have equal benefit with regard to reduction of
cardiovascular disase and diabetes,45 46 it seems likely that
benefits of coffee are from bioflavonoids.
Both green tea and other forms of tea reduce cardio-
vascular risk. Green tea lowers blood pressure and LDL
cholesterol,47 and improves endothelial function.48
However, there are differences between green tea and
black tea. A report from the Rotterdam study49 indicated
that consumption of the bioflavonoids quercetin, kaemp-
ferol and myricetin may account for the reduction of
myocardial infarction observed with black tea consump-
tion. The cardiovascular benefit of green tea, on the
other hand, has been associated with catechins.50
Consumption of both tea and coffee appears to be
beneficial. It is not known if consuming both tea and
coffee would be more beneficial. Since consumption of
these beverages is a personal preference with cultural
differences across countries, it seems unlikely that physi-
cians would prescribe one or the other.
CONSUMPTION OF ALCOHOL
Consumption of alcohol is a two-edged sword. Moderate
consumption of alcohol (<9 standard drinks per week for
women or 14 for men)51 appears to reduce cardiovas-
cular risk compared with drinking no alcohol,52 whereas
heavy consumption increases risk, particularly for stroke,
and particularly for intracerebral haemorrhage. In a
recent large population-based study (n=114 859, followed
for 6 years)52: ‘Heavy drinking (exceeding guidelines)
conferred an increased risk of presenting with unheralded
coronary death (1.21, 95% CI 1.08 to 1.35), heart failure
(1.22, 1.08 to 1.37), cardiac arrest (1.50, 1.26 to 1.77),
transient ischaemic attack (1.11, 1.02 to 1.37), ischaemic
stroke (1.33, 1.09 to 1.63), intracerebral haemorrhage
(1.37, 1.16 to 1.62), and peripheral arterial disease (1.35;
1.23 to 1.48), but a lower risk of myocardial infarction
(0.88, 0.79 to 1.00) or stable angina (0.93, 0.86 to 1.00)’.
Two likely mechanisms are that heavy alcohol consump-
tion may increase the risk of atrial fibrillation and also
increase blood pressure,51 in some individuals more than
others. Moderate alcohol consumption does not appear
to increase the risk of atrial fibrillation.53
DIETARY SODIUM
A major dietary issue in China is sodium intake. The
relationship of sodium intake to hypertension in China
was reviewed in 2014.54 Most of the sodium (~75%) in
the diet comes from soy sauce and added condiments.
The major cause of stroke in China is hypertension, and
hypertension is poorly controlled,55 in part because of the
cost of medication.56 Restriction of sodium intake has the
potential to improve blood pressure control, particularly
in patients with higher blood pressures,11 at no finan-
cial cost. Patients should be encouraged to use light soy
sauce in limited quantities and increase other approaches
to flavouring food, such as lemon juice, vinegar, ginger,
spices, herbs and hot peppers. Again, such changes would
represent a cultural change that would be a challenge to
implement.
So what diet would be recommended for patientsat risk of
stroke?
Patients at risk of stroke should limit their intake of
animal flesh, avoiding red meat and egg yolk. They
should have a high intake of beneficial oils such as olive
and canola, whole grains, vegetables, fruits and legumes.
Egg white is a good source of protein, so omelettes, frit-
tatas and egg salad sandwiches made with egg whites or
with egg white-based substitutes are a good substitute for
a meat-based meal. Box 2 summarises my recommenda-
tions for helping patients learn to make a healthy diet
enjoyable. The recipe booklet that I give to my patients
Box 2 Dietary recommendations for patients at risk of
stroke
No egg yolks: use egg whites, egg beaters, egg creations or similar
substitutes.
Flesh of any animal: a serving the size of the palm of the hand or
less,~every other day (or half that daily).
Seldom red meat, mainly fish and chicken.
High intake of olive oil andcanola oil.
Only whole grains.
High intake of vegetables, fruit andlegumes.
Avoid deep-fried foods andhydrogenated oils (trans fats).
Avoid sugar and refined grains, and limit potatoes.
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
49
SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
can be downloaded from http://www. imaging. robarts.
ca/ SPARC/.
To accomplish this, patients need to think of their
meatless day not as a punishment day, but as a gourmet
cooking class day: ‘Having fun learning how to make
healthy eating tasty’.57
A measure that should be considered in China would
be converting the population to whole grain rice instead
of polished rice. This would no doubt be extremely diffi-
cult, but it would reduce the risk of diabetes, stroke and
myocardial infarction.
CONCLUSION
Diet is an important part of stroke prevention. Reducing
sodium intake, avoiding egg yolks, limiting the intake of
animal flesh (particularly red meat), and increasing the
intake of whole grains, fruits, vegetables and lentils would
contribute importantly to reversing the trend to increased
cardiovascular risk in China.
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Guest chief editor J David Spence
Open access This is an open access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is
properly cited and the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the
article) 2018. All rights reserved. No commercial use is permitted unless otherwise
expressly granted.
RefeRences
1. Hackam DG, Spence JD. Combining multiple approaches for the
secondary prevention of vascular events after stroke: a quantitative
modeling study. Stroke 2007;38:1881–5.
2. Chiuve SE, Rexrode KM, Spiegelman D, et al. Primary prevention of
stroke by healthy lifestyle. Circulation 2008;118:947–54.
3. Larsson SC, Akesson A, Wolk A. Healthy diet and lifestyle and
risk of stroke in a prospective cohort of women. Neurology
2014;83:1699–704.
4. Akesson A, Larsson SC, Discacciati A, et al. Low-risk diet and
lifestyle habits in the primary prevention of myocardial infarction in
men: a population-based prospective cohort study. J Am Coll Cardiol
2014;64:1299–306.
5. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and
stroke statistics--2015 update: a report from the American Heart
Association. Circulation 2015;131:e29–322.
6. Weiwei C, Runlin G, Lisheng L, et al. Outline of the report on
cardiovascular diseases in China, 2014. Eur Heart J Suppl
2016;18(Suppl F):F2–11.
7. Reddy KS. Cardiovascular disease in non-Western countries. N Engl
J Med 2004;350:2438–40.
8. Critchley JA, Capewell S. Mortality risk reduction associated with
smoking cessation in patients with coronary heart disease: a
systematic review. JAMA 2003;290:86–97.
9. Bogiatzi C, Hackam DG, McLeod AI, et al. Secular trends in ischemic
stroke subtypes and stroke risk factors. Stroke 2014;45:3208–13.
10. Willett WC, Stampfer MJ. Rebuilding the food pyramid. Sci Am
2003;288:64–71.
11. Juraschek SP, Miller ER, Weaver CM, et al. Effects of sodium
reduction and the DASH diet in relation to baselineblood pressure.
J Am Coll Cardiol 2017;70:2841–8.
12. Keys A. Mediterranean diet and public health: personal reections.
Am J Clin Nutr 1995;61(6 Suppl):1321S–3.
13. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet
for prevention of coronary heart disease. Am J Clin Nutr 1995;61(6
Suppl):1360S–7.
14. Group SSSS. Randomised trial of cholesterol lowering in 4444
patients with coronary heart disease: the Scandinavian Simvastatin
Survival Study (4S). Lancet 1994;344:1383–9.
15. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of
cardiovascular disease with a Mediterranean diet. N Engl J Med
2013;368:1279–90.
16. Spence JD. Are some diets “mass murder”? Mediterranean diet is
not to blame for increased carbohydrate intake. BMJ 2015;350:h613.
17. Nestle M. Food industry funding of nutrition research: the
relevance of history for current debates. JAMA Intern Med
2016;176:1685–6.
18. Kearns CE, Schmidt LA, Glantz SA. Sugar industry and coronary
heart disease research: a historical analysis of internal industry
documents. JAMA Intern Med 2016;176:1680–5.
19. Spence JD. Red meat intake and cardiovascular risk: it’s the events
that matter; not the risk factors. J Public Health Emerg 2017;1:53.
20. Greger M. False and misleading claims by egg marketers: secondary
false and misleading claims by egg marketers. 2013. http://
nutritionfacts. org/ video/ eggs- and- cholesterol- patently- false- and-
misleading-claims/ (accessed 20 May 2015).
21. Greger M. How the Egg Board Designs Misleading Studies
:Secondary How the Egg Board Designs Misleading Studies.
2013. http:// nutritionfacts. org/ video/ how- the- egg- board- designs-
misleading- studies/ (accessed 20 May 2015).
22. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-
carbohydrate, Mediterranean, or low-fat diet. N Engl J Med
2008;359:229–41.
23. Spence JD. Fasting lipids: the carrot in the snowman. Can J Cardiol
2003;19:890–2.
24. Spence JD, Jenkins DJ, Davignon J. Dietary cholesterol and egg
yolks: not for patients at risk of vascular disease. Can J Cardiol
2010;26:e336–e339.
25. Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin
concentrations and the expression of Toll-like receptors and
suppressor of cytokine signaling-3 in mononuclear cells after a
high-fat, high-carbohydrate meal: implications for insulin resistance.
Diabetes Care 2009;32:2281–7.
26. Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg
consumption and risk of cardiovascular disease in men and women.
JAMA 1999;281:1387–94.
27. Qureshi AI, Suri FK, Ahmed S, et al. Regular egg consumption does
not increase the risk of stroke and cardiovascular diseases. Med Sci
Monit 2007;13:CR1–8.
28. Trichopoulou A, Psaltopoulou T, Orfanos P, et al. Diet and physical
activity in relation to overall mortality amongst adult diabetics in a
general population cohort. J Intern Med 2006;259:583–91.
29. Djoussé L, Gaziano JM, Buring JE, et al. Egg consumption
and risk of type 2 diabetes in men and women. Diabetes Care
2009;32:295–300.
30. Healthy people 2000: National health promotion and disease
prevention objectives. United States Department of Health and
Human Services, 1991.
31. Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS Guidelines
for the management of dyslipidaemias the task force for the
management of dyslipidaemias of the European Society of
Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Atherosclerosis 2011;217:3–46.
32. Wilkins JT, Ning H, Berry J, et al. Lifetime risk and years lived free of
total cardiovascular disease. JAMA 2012;308:1795–801.
33. Spence JD, Jenkins DJ, Davignon J. Egg yolk consumption and
carotid plaque. Atherosclerosis 2012;224:469–73.
34. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and
death from coronary heart disease. The Western Electric study.
N Engl J Med 1981;304:65–70.
35. Kushi LH, Lew RA, Stare FJ, et al. Diet and 20-year mortality from
coronary heart disease. The Ireland-Boston Diet-Heart Study. N Engl
J Med 1985;312:811–8.
36. Spence JD. Effects of the intestinal microbiome on constituents
of red meat and egg yolks: a new window opens on nutrition and
cardiovascular disease. Can J Cardiol 2014;30:150–1.
37. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota
metabolism of l-carnitine, a nutrient in red meat, promotes
atherosclerosis. Nat Med 2013;19:576–85.
38. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism
of phosphatidylcholine and cardiovascular risk. N Engl J Med
2013;368:1575–84.
39. Hardees. Secondary. http://www. hardees. com/ menu/ nutritional_
calculator
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
50 SpenceJD. Stroke and Vascular Neurology 2018;3:e000130. doi:10.1136/svn-2017-000130
Open access
40. Spence JD, Urquhart BL, Bang H. Effect of renal impairment on
atherosclerosis: only partially mediated by homocysteine. Nephrol
Dial Transplant 2016;31:937–44.
41. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic
kidney disease and cardiovascular risk: epidemiology, mechanisms,
and prevention. Lancet 2013;382:339–52.
42. Sesso HD, Gaziano JM, Buring JE, et al. Coffee and tea intake and
the risk of myocardial infarction. Am J Epidemiol 1999;149:162–7.
43. Cornelis MC, El-Sohemy A, Kabagambe EK, et al. Coffee,
CYP1A2 genotype, and risk of myocardial infarction. JAMA
2006;295:1135–41.
44. Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption
and health: umbrella review of meta-analyses of multiple health
outcomes. BMJ 2017;359:j5024.
45. Ding M, Bhupathiraju SN, Satija A, et al. Long-term coffee
consumption and risk of cardiovascular disease: a systematic review
and a dose-response meta-analysis of prospective cohort studies.
Circulation 2014;129:643–59.
46. Ding M, Bhupathiraju SN, Chen M, et al. Caffeinated and decaffeinated
coffee consumption and risk of type 2 diabetes: a systematic review
and a dose-response meta-analysis. Diabetes Care 2014;37:569–86.
47. Onakpoya I, Spencer E, Heneghan C, et al. The effect of green tea
on blood pressure and lipid prole: a systematic review and meta-
analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis
2014;24:823–36.
48. Park CS, Kim W, Woo JS, et al. Green tea consumption improves
endothelial function but not circulating endothelial progenitor cells in
patients with chronic renal failure. Int J Cardiol 2010;145:261–2.
49. Geleijnse JM, Launer LJ, Van der Kuip DA, et al. Inverse association
of tea and avonoid intakes with incident myocardial infarction: the
Rotterdam Study. Am J Clin Nutr 2002;75:880–6.
50. Chacko SM, Thambi PT, Kuttan R, et al. Benecial effects of green
tea: a literature review. Chin Med 2010;5:13.
51. Campbell NR, Ashley MJ, Carruthers SG, et al. Lifestyle
modications to prevent and control hypertension. 3.
Recommendations on alcohol consumption. Canadian Hypertension
Society, Canadian Coalition for High Blood Pressure Prevention
and Control, Laboratory Centre for Disease Control at Health
Canada, Heart and Stroke Foundation of Canada. CMAJ 1999;160(9
Suppl):S13–20.
52. Bell S, Daskalopoulou M, Rapsomaniki E, et al. Association between
clinically recorded alcohol consumption and initial presentation of 12
cardiovascular diseases: population based cohort study using linked
health records. BMJ 2017;356:j909.
53. Gémes K, Malmo V, Laugsand LE, et al. Does moderate drinking
increase the risk of atrial brillation? The Norwegian HUNT (Nord-
Trøndelag Health) Study. J Am Heart Assoc 2017;6:e007094.
54. Du S, Neiman A, Batis C, et al. Understanding the patterns and
trends of sodium intake, potassium intake, and sodium to potassium
ratio and their effect on hypertension in China. Am J Clin Nutr
2014;99:334–43.
55. Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and
control of hypertension in China: data from 1.7 million adults in a
population-based screening study (China PEACE Million Persons
Project). Lancet 2017.
56. Su M, Zhang Q, Bai X, et al. Availability, cost, and prescription
patterns of antihypertensive medications in primary health
care in China: a nationwide cross-sectional survey. Lancet
2017;390:2559–68.
57. Spence JD. How to prevent your stroke. Nashville, TN: Vanderbilt
University Press, 2006.
58. Wang Z, Klipfell E, Bennett BJ, et al. Gut ora metabolism of
phosphatidylcholine promotes cardiovascular disease. Nature
2011;472:57–63.
on 15 July 2018 by guest. Protected by copyright.http://svn.bmj.com/Stroke Vasc Neurol: first published as 10.1136/svn-2017-000130 on 13 January 2018. Downloaded from
... Specifically, there has been an increase in the consumption of CHOLESTEROL METABOLISM AND ITS PROINFLAMMATORY ROLE meats and eggs, while the intake of fruits, vegetables, and whole grains has decreased. [92] For example, in China, from 1992 to 2012, the proportion of energy provided by fat in the diet of Chinese residents increased from 16.0% to 32.3%, the intake of red meat increased from 42.2 g/d to 64.4 g/d, while the intake of eggs increased from 13.5 to 23.5 g/day. [93] Meats and eggs, in addition to being rich in protein, are also high in cholesterol and are major contributors to dietary cholesterol. ...
... [93] Meats and eggs, in addition to being rich in protein, are also high in cholesterol and are major contributors to dietary cholesterol. [94] It has been demonstrated that the yolk of a 65 g egg contains 237 mg of cholesterol, [92] 100 g of cooked mutton contains 130 mg of cholesterol. [95] Additionally, organ meats, such as beef liver and lamb liver, have a more higher cholesterol content. ...
Article
Full-text available
Cholesterol is an essential lipid molecule in mammalian cells. It is not only involved in the formation of cell membranes but also serves as a raw material for the synthesis of bile acids, vitamin D, and steroid hormones. Additionally, it acts as a covalent modifier of proteins and plays a crucial role in numerous life processes. Generally, the metabolic processes of cholesterol absorption, synthesis, conversion, and efflux are strictly regulated. Excessive accumulation of cholesterol in the body is a risk factor for metabolic diseases such as cardiovascular disease, type 2 diabetes, and metabolic dysfunction–associated steatotic liver disease (MASLD). In this review, we first provide an overview of the discovery of cholesterol and the fundamental process of cholesterol metabolism. We then summarize the relationship between dietary cholesterol intake and the risk of developing MASLD, and also the animal models of MASLD specifically established with a cholesterol-containing diet. In the end, the role of cholesterol-induced inflammation in the initiation and development of MASLD is discussed.
... Physical activity remains a powerful means of lowering the IS mortality risk from meat intake; however, the overall consumption of red and processed meats, particularly the latter, should be controlled (38). Primary prevention of IS includes lifestyle and dietary changes and treatment of risk factors such as high blood pressure, diabetes, and lipid disorders (39)(40)(41). A prospective cohort study of half a million middle-aged and older Chinese individuals demonstrated a significant reduction in IS risk with a healthy lifestyle including lower red meat intake, active exercise, and higher vegetable consumption (42). ...
Article
Full-text available
Background The burden of ischemic stroke (IS) linked to high consumption of red meat is on the rise. This study aimed to analyze the mortality and disability-adjusted life years (DALYs) trends for IS attributed to high red meat intake in China between 1990 and 2019 and to compare these trends with global trends. Methods This study extracted data on IS attributed to diets high in red meat in China from 1990 to 2019 from the Global Burden of Disease Study (GBD) database. Key measures, including mortality, DALYs, age-standardized mortality rates (ASMR), and age-standardized DALYs rates (ASDR), were used to estimate the disease burden. The estimated annual percentage change and joinpoint regression models were employed to assess the trends over time. An age-period-cohort analysis was used to assess the contribution of a diet high in red meat to the age, period, and cohort effects of IS ASMR and ASDR. Results Between 1990 and 2019, deaths and DALYs from IS attributed to a diet high in red meat in China, along with corresponding age-standardized rates, significantly increased. The overall estimated annual percentage change for the total population and across sex categories ranged from 1.01 to 2.08. The average annual percentage changes for overall ASDR and ASMR were 1.4 and 1.33, respectively, with male ASDR and ASMR average annual percentage changes at 1.69 and 1.69, respectively. Contrastingly, female ASDR and ASMR average annual percentage changes were 1.07 and 0.87, respectively. Except for a few periods of significant decrease in females, all other periods indicated a significant increase or nonsignificant changes. Incidence of IS linked to a diet high in red meat rose sharply with age, displaying increasing period and cohort effects in ASDR. Female ASMR period and cohort effect ratios initially increased and then decreased, whereas the male ratio showed an upward trend. Conclusion This study comprehensively analyzed epidemiological characteristics that indicated a marked increase in mortality and DALYs from IS attributable to high red meat consumption, contrasting with a global downtrend. This increase was more pronounced in males than females. This research provides valuable insights for enhancing IS prevention in China.
... First, we excluded participants who did not have blood samples, which could lead to selective bias. Second, some confounding factors of the association between TyG index and stroke, such as diet (42), physical activity (43), and family history of stroke (44) were not adjusted in this study. Third, as with many studies, stroke diagnosis in this research was based on self-reporting, posing a methodological challenge. ...
Article
Full-text available
Background: Triglyceride-glucose (TyG) index and hypertension were well-established risk factors for stroke. And TyG index was associated with hypertension. However, no prior study has investigated the interactive effects of the TyG index and hypertension on stroke. This study examined whether hypertension mediates associations of TyG index with incident stroke and the extent of interaction or joint relations of TyG index and hypertension with stroke in middle-aged and older Chinese adults. Methods: The China Health and Retirement Longitudinal Study (CHARLS) is an ongoing nationally representative prospective cohort study initiated in 2011. This cohort study included 9,145 middle-aged and older Chinese adults without stroke at baseline. The eposures were TyG index and the logarithmized product of hypertension, as determined during the baseline health examination. The main outcome was self-reported physician-diagnosed stroke which followed up from June 1, 2011, to June 30, 2018. Results: Of the 9,145 participants, 4,251 were men (46.5%); the mean (SD) age was 59.20 (9.33) years. During a median follow-up of 7.1 years, 637 (7.0%) participants developed stroke. In multivariable-adjusted models, the TyG index was significantly associated with the risk of hypertension [odds ratio (OR) per 1-SD increase, 1.29; 95% CI, 1.19-1.41] and stroke [hazard ratio (HR) per 1-SD increase, 1.16; 95% CI, 1.02-1.33]. Both multiplicative and additive interactions were observed between TyG index and hypertension on stroke (HR for multiplicative: 2.34, 95% CI, 1.57-3.48; Synergy index: 4.13, 95% CI, 2.73-6.25). Mediation analysis showed that 20.0% of the association between TyG index and stroke was mediated through hypertension. Conclusions: This study suggests a synergistic effect of TyG index and hypertension on stroke, and a small proportion of the association between TyG index and stroke was mediated by hypertension, indicating the benefit of coordinated control strategies for both exposures.
... The traditional Chinese medicine Tong-Qiao-Huo-Xue Decoction can control changes in the bacterial community post IS, reduce excessive increases in Bacteroides, control abnormal changes in the abundance of specific bacterial communities, improve the inflammatory response caused by T-cell imbalance, and restore the function of the intestinal barrier (Spence, 2018). Combining Pueraria lobata root and Chuanxiong Rhizoma (CXR) in treating IS in rats has been shown to alleviate intestinal microbiota imbalance and damage to the brain-intestinal barrier, effectively improving neurological function (Chen et al., 2019a). ...
Article
Full-text available
Ischemic stroke (IS) is a serious central nervous system disease. Post-IS complications, such as post-stroke cognitive impairment (PSCI), post-stroke depression (PSD), hemorrhagic transformation (HT), gastrointestinal dysfunction, cardiovascular events, and post-stroke infection (PSI), result in neurological deficits. The microbiota-gut-brain axis (MGBA) facilitates bidirectional signal transduction and communication between the intestines and the brain. Recent studies have reported alterations in gut microbiota diversity post-IS, suggesting the involvement of gut microbiota in post-IS complications through various mechanisms such as bacterial translocation, immune regulation, and production of gut bacterial metabolites, thereby affecting disease prognosis. In this review, to provide insights into the prevention and treatment of post-IS complications and improvement of the long-term prognosis of IS, we summarize the interaction between the gut microbiota and IS, along with the effects of the gut microbiota on post-IS complications.
... About 30% of ischemic stroke patients have diagnosed type 2 diabetes mellitus (T2D) [2], which is an established predictor of poor functional outcome [3,4] and hampered recovery after stroke [5][6][7], thereby further amplifying the global disability burden. Although both pharmacological and lifestyle change strategies can reduce stroke risk in T2D [8][9][10][11], there are currently no effective therapies targeting impaired post-stroke recovery, emphasizing the necessity for new pharmacological treatments. ...
Article
Full-text available
Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities. Currently, there are no therapies targeting this important clinical problem. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are potent anti-diabetic drugs that also efficiently reduce cardiovascular death and heart failure. In addition, SGLT2i facilitate several processes implicated in stroke recovery. However, the potential efficacy of SGLT2i to improve stroke recovery in T2D has not been investigated. Therefore, we determined whether a post-stroke intervention with the SGLT2i Empagliflozin could improve stroke recovery in T2D mice. T2D was induced in C57BL6J mice by 8 months of high-fat diet feeding. Hereafter, animals were subjected to transient middle cerebral artery occlusion and treated with vehicle or the SGLTi Empagliflozin (10 mg/kg/day) starting from 3 days after stroke. A similar study in non diabetic mice was also conducted. Stroke recovery was assessed using the forepaw grip strength test. To identify potential mechanisms involved in the Empagliflozin-mediated effects, several metabolic parameters were assessed. Additionally, neuronal survival, neuroinflammation, neurogenesis and cerebral vascularization were analyzed using immunohistochemistry/quantitative microscopy. Empagliflozin significantly improved stroke recovery in T2D but not in non-diabetic mice. Improvement of functional recovery was associated with lowered glycemia, increased serum levels of fibroblast growth factor-21 (FGF-21), and the normalization of T2D-induced aberration of parenchymal pericyte density. The global T2D-epidemic and the fact that T2D is a major risk factor for stroke are drastically increasing the number of people in need of efficacious therapies to improve stroke recovery. Our data provide a strong incentive for the potential use of SGLT2i for the treatment of post-stroke sequelae in T2D. Supplementary Information The online version contains supplementary material available at 10.1186/s12933-024-02174-6.
... This hypothesis paves the way for a genetically informed understanding of dietary approaches for stroke prevention, such as the DASH (Medication and Dietary Approaches to Stop Hypertension) pattern. 35 Based on the PhenoScanner (a database of human genotype-phenotype association), we found rs78852205 related with vascular or heart problems diagnosed by doctor, which was the selected IV in the casuality between species B. pectinophilus on CES. The Negativicutes class comprises Gram-negative bacteria characterised by double membranes and encompasses 31 genera. ...
Article
Full-text available
Background and aims Observational studies have implicated the involvement of gut microbiome in stroke development. Conversely, stroke may disrupt the gut microbiome balance, potentially causing systemic infections exacerbated brain infarction. However, the causal relationship remains controversial or unknown. To investigate bidirectional causality and potential ethnic differences, we conducted a bidirectional two-sample Mendelian randomisation (MR) study in both East Asian (EAS) and European (EU) populations. Methods Leveraging the hitherto largest genome-wide association study (GWAS) summary data from the MiBioGen Consortium (n=18 340, EU) and BGI (n=2524, EAS) for the gut microbiome, stroke GWAS data from the GIGASTROKE Consortium(264 655 EAS and 1 308 460 EU), we conducted bidirectional MR and sensitivity analyses separately for the EAS and EU population. Results We identified nominally significant associations between 85 gut microbiomes taxa in EAS and 64 gut microbiomes taxa in EU with stroke or its subtypes. Following multiple testing, we observed that genetically determined 1 SD increase in the relative abundance of species Bacteroides pectinophilus decreased the risk of cardioembolic stroke onset by 28% (OR 0.72 (95% CI 0.62 to 0.84); p=4.22e−5), and that genetically determined 1 SD increase in class Negativicutes resulted in a 0.76% risk increase in small vessel stroke in EAS. No significant causal association was identified in the EU population and the reverse MR analysis. Conclusion Our study revealed subtype-specific and population-specific causal associations between gut microbiome and stroke risk among EAS and EU populations. The identified causality holds promise for developing a new stroke prevention strategy, warrants further mechanistic validation and necessitates clinical trial studies.
... The Dietary Approaches to Stop Hypertension (DASH) diet was recommended by promoting the consumption of fruits, vegetables, and low-fat dairy products while advocating for reduced intake of saturated fat, overall fat, and cholesterol. It encouraged the inclusion of whole grains, poultry, fish, and nuts while discouraging the consumption of red meat, sweets, and sugarcontaining beverages (Spence 2018). Alcohol consumption, substance abuse, and smoking have varying impacts on stroke risk, depending on the type of stroke. ...
Article
Full-text available
This case study aims to report on the nutrition management of acute stroke with right-sided hemiparesis using an approach of early enteral feeding intervention to prevent malnutrition. Mr. R, a 77-year-old Malay man was admitted to the hospital due to an acute stroke with right hemiparesis with underlying disease of Atrial Fibrillation (AF), hypertension, type 2 Diabetes Mellitus (DM), Chronic Kidney Disease (CKD) stage 3b, and significant Peripheral Artery Disease (PAD). His BMI was 24kg/m2 with a weight of 67kg and height of 1.67m, and he was presented with abnormal blood results. All his vital signs were normal, and he appeared lethargic. The patient was on bolus Nasogastric (NG) feeding via Ryle’s tube with polymeric formula. Inadequate enteral nutrition infusion related to infusion volume not yet reached, as evidenced by a 47% energy and 60% protein adequacy feeding history. The polymeric formula was changed to a diabetic-specific formula for better blood sugar control, and feeding was given according to the patient's needs. Mr. R required at least 70% of 1,675 kcal of energy and 53.6 g of protein (0.8 g/kg body weight) to prevent malnutrition. The patient was still on Ryle’s tube feeding and already achieved the targeted energy and protein requirements. Before being discharged, the patient was allowed orally, and a sample menu was given as guidance to avoid weight loss and muscle wasting during longterm recovery. This case highlights the importance of early enteral feeding support in stroke recovery and the need to prioritize meeting nutritional needs in stroke patient care. Mr. R showed improvement in health and nutrition and concluded that early and focused enteral nutrition support can lead to improved results and better quality of life for stroke survivors.
... [31] Reducing salt intake to <5 grams per day is another strategy considered to reduce the risk of cardiovascular mortality in hypertensive participants. [32] Another primordial prevention strategy is to limit the intake of foods associated with overnutrition (e.g., sugar-sweetened beverages). A study reported that a reduction in the consumption of sugar-sweetened beverages by 10% would result in 20,000 fewer strokes and 19,000 fewer deaths annually. ...
Article
Full-text available
Ischemic stroke is a considerable public health hazard and a significant cause of disability and mortality in Saudi Arabia. Primary prevention strategies in the country are currently limited. With the health sector transformation program that depends on the principles of value-based care and applying the new model of care in disease prevention, aggressive and serious steps for primary stroke prevention are expected to be implemented. This article reviews primordial and primary prevention of ischemic stroke in Saudi Arabia and suggests a combination approach and framework for implementation. We provide a pragmatic solution to implement primordial and primary stroke prevention in Saudi Arabia and specify the roles of the government, health professionals, policymakers, and the entire population. Currently, there are several key priorities for primordial and primary stroke prevention in Saudi Arabia that should target people at different levels of risk. These include an emphasis on a comprehensive approach that includes both individual and population-based strategies and establishing partnerships across health-care providers to share responsibility for developing and implementing both strategies. This is an urgent call for action to initiate different strategies suggested by experts for primary stroke prevention in Saudi Arabia.
Article
Aim: To investigate the associations of individual and combined healthy lifestyle factors (HLS) with the risk of stroke in individuals with diabetes in China. Methods: This prospective analysis included 41 314 individuals with diabetes [15 191 from the Comprehensive Research on the Prevention and Control of the Diabetes (CRPCD) project and 26 123 from the China Kadoorie Biobank (CKB) study]. Associations of lifestyle factors, including cigarette smoking, alcohol consumption, physical activity, diet, body shape and sleep duration, with the risk of stroke, intracerebral haemorrhage (ICH) and ischaemic stroke (IS) were assessed using Cox proportional hazard models. Results: During median follow-up periods of 8.02 and 9.05 years, 2499 and 4578 cases of stroke, 2147 and 4024 of IS, and 160 and 728 of ICH were documented in individuals with diabetes in the CRPCD and CKB cohorts, respectively. In the CRPCD cohort, patients with ≥5 HLS had a 14% lower risk of stroke (hazard ratio (HR): 0.86, 95% confidence interval (CI): 0.75-0.98) than those with ≤2 HLS. In the CKB cohort, the adjusted HR (95% CI) for patients with ≥5 HLS were 0.74 (0.66-0.83) for stroke, 0.74 (0.66-0.83) for IS, and 0.57 (0.42-0.78) for ICH compared with those with ≤2 HLS. The pooled adjusted HR (95% CI) comparing patients with ≥5 HLS versus ≤2 HLS was 0.79 (0.69-0.92) for stroke, 0.80 (0.68-0.93) for IS, and 0.60 (0.46-0.78) for ICH. Conclusions: Maintaining a healthy lifestyle was associated with a lower risk of stroke, IS and ICH among individuals with diabetes.
Article
Background Stroke is the second-leading cause of death and the third-leading cause of disability in the general population worldwide. However, the changing trend of ischemic stroke burden attributable to various dietary risk factors has not been fully revealed and may contribute to a better understanding of stroke epidemiology. Aims Our paper aimed to evaluate the temporal trend of diet-related ischemic stroke burden to inform future research and policy-making. Methods This analysis was based on the data from the Global Burden of Disease (GBD) Study 2019 (spanning years 1990 to 2019) and we used the joinpoint regression to model temporal trends in diet-related ischemic stroke burden across countries and regions of the world during the study period. Six specific dietary factors known to influence stroke risk, including sodium, red meat, fiber, vegetables, whole grains, and fruits, were evaluated in the GBD study to determine their individual and joint impact on ischemic stroke. The changing trend was primarily measured by the average annual percent change (AAPC). Age-standardized rates (ASR) of mortality and years lived with disability (YLD) per 100,000 population were used to evaluate disease burden. Finally, the socioeconomic background, which was quantified as sociodemographic index (SDI), and its association with diet-related ischemic stroke burden was also explored with the Pearson correlation coefficient. Results During the study period, the ischemic stroke ASR of mortality attributable to overall dietary risk decreased by an average of 1.6% per year, while the ASR of YLD decreased by an average of 0.2% per year. High sodium diet was still a key driver of diet-related ischemic stroke, accounting for 8.4% and 11.0% of deaths and disabilities respectively in 2019. Additionally, we found a negative association between temporal evolution of stroke burden and socioeconomic background (r=-0.6603 for mortality and r=-0.4224 for disability, P<0.001), which suggested that the developing countries with weak social and economic foundation faced greater challenges from the ongoing burden of diet-related strokes compared to developed countries. Conclusions Our study found declining trends and revealed the current status of diet-related ischemic stroke mortality and disability. Interdisciplinary countermeasures involving the development of effective food policies, evidence-based guidelines, and public education are needed in the future to combat this global epidemic. Data access statement The data used for analysis were open-access and can be obtained from https://vizhub.healthdata.org/gbd-results/ .
Article
Full-text available
Objectives To evaluate the existing evidence for associations between coffee consumption and multiple health outcomes. Design Umbrella review of the evidence across meta-analyses of observational and interventional studies of coffee consumption and any health outcome. Data sources PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews, and screening of references. Eligibility criteria for selecting studies Meta-analyses of both observational and interventional studies that examined the associations between coffee consumption and any health outcome in any adult population in all countries and all settings. Studies of genetic polymorphisms for coffee metabolism were excluded. Results The umbrella review identified 201 meta-analyses of observational research with 67 unique health outcomes and 17 meta-analyses of interventional research with nine unique outcomes. Coffee consumption was more often associated with benefit than harm for a range of health outcomes across exposures including high versus low, any versus none, and one extra cup a day. There was evidence of a non-linear association between consumption and some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a day versus none, including all cause mortality (relative risk 0.83, 95% confidence interval 0.83 to 0.88), cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90). High versus low consumption was associated with an 18% lower risk of incident cancer (0.82, 0.74 to 0.89). Consumption was also associated with a lower risk of several specific cancers and neurological, metabolic, and liver conditions. Harmful associations were largely nullified by adequate adjustment for smoking, except in pregnancy, where high versus low/no consumption was associated with low birth weight (odds ratio 1.31, 95% confidence interval 1.03 to 1.67), preterm birth in the first (1.22, 1.00 to 1.49) and second (1.12, 1.02 to 1.22) trimester, and pregnancy loss (1.46, 1.06 to 1.99). There was also an association between coffee drinking and risk of fracture in women but not in men. Conclusion Coffee consumption seems generally safe within usual levels of intake, with summary estimates indicating largest risk reduction for various health outcomes at three to four cups a day, and more likely to benefit health than harm. Robust randomised controlled trials are needed to understand whether the observed associations are causal. Importantly, outside of pregnancy, existing evidence suggests that coffee could be tested as an intervention without significant risk of causing harm. Women at increased risk of fracture should possibly be excluded.
Article
Full-text available
Background Around 200 million adults in China have hypertension, but few are treated or achieve adequate control of their blood pressure. Available and affordable medications are important for successfully controlling hypertension, but little is known about current patterns of access to, and use of, antihypertensive medications in Chinese primary health care. Methods We used data from a nationwide cross-sectional survey (the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project primary health care survey), which was undertaken between November, 2016 and May, 2017, to assess the availability, cost, and prescription patterns of 62 antihypertensive medications at primary health-care sites across 31 Chinese provinces. We surveyed 203 community health centres, 401 community health stations, 284 township health centres, and 2474 village clinics to assess variation in availability, cost, and prescription by economic region and type of site. We also assessed the use of high-value medications, defined as guideline-recommended and low-cost. We also examined the association of medication cost with availability and prescription patterns. Findings Our study sample included 3362 primary health-care sites and around 1 million people (613 638 people at 2758 rural sites and 478 393 people at 604 urban sites). Of the 3362 sites, 8·1% (95% CI 7·2–9·1) stocked no antihypertensive medications and 33·8% (32·2–35·4) stocked all four classes that were routinely used. Village clinics and sites in the western region of China had the lowest availability. Only 32·7% (32·2–33·3) of all sites stocked high-value medications, and few high-value medications were prescribed (11·2% [10·9–11·6] of all prescription records). High-cost medications were more likely to be prescribed than low-cost alternatives. Interpretation China has marked deficiencies in the availability, cost, and prescription of antihypertensive medications. High-value medications are not preferentially used. Future efforts to reduce the burden of hypertension, particularly through the work of primary health-care providers, will need to improve access to, and use of, antihypertensive medications, paying particular attention to those with high value.
Article
Full-text available
Background Compelling evidence suggests that excessive alcohol consumption increases the risk of atrial fibrillation (AF), but the effect of light‐moderate alcohol consumption is less certain. We investigated the association between alcohol consumption within recommended limits and AF risk in a light‐drinking population. Methods and Results Among 47 002 participants with information on alcohol consumption in a population‐based cohort study in Norway, conducted from October 2006 to June 2008, 1697 validated AF diagnoses were registered during the 8 years of follow‐up. We used Cox proportional hazard models with fractional polynomials to analyze the association between alcohol intake and AF. Population attributable risk for drinking within the recommended limit (ie, at most 1 drink per day for women and 2 drinks per day for men without risky drinking) compared with nondrinking was also calculated. The average alcohol intake was 3.8±4.8 g/d. The adjusted hazard ratio for AF was 1.38 (95% confidence interval, 1.06–1.80) when we compared participants consuming >7 drinks per week with abstainers. When we modeled the quantity of alcohol intake as a continuous variable, the risk increased in a curvilinear manner. It was higher with heavier alcohol intake, but there was virtually no association at <1 drink per day for women and <2 drinks per day for men in the absence of risky drinking. The population attributable risk among nonrisky drinkers was 0.07% (95% confidence interval, −0.01% to 0.13%). Conclusions Although alcohol consumption was associated with a curvilinearly increasing risk of AF in general, the attributable risk of alcohol consumption within recommended limits among participants without binge or problem drinking was negligible in this population.
Article
Full-text available
\textbf{Objectives }$ To investigate the association between alcohol consumption and cardiovascular disease at higher resolution by examining the initial lifetime presentation of 12 cardiac, cerebrovascular, abdominal, or peripheral vascular diseases among five categories of consumption. $\textbf{Design}$ Population based cohort study of linked electronic health records covering primary care, hospital admissions, and mortality in 1997-2010 (median follow-up six years). $\textbf{Setting }$ CALIBER (ClinicAl research using LInked Bespoke studies and Electronic health Records). $\textbf{Participants }$ 1 937 360 adults (51% women), aged ≥30 who were free from cardiovascular disease at baseline. $\textbf{Main outcome measures}$ 12 common symptomatic manifestations of cardiovascular disease, including chronic stable angina, unstable angina, acute myocardial infarction, unheralded coronary heart disease death, heart failure, sudden coronary death/cardiac arrest, transient ischaemic attack, ischaemic stroke, intracerebral and subarachnoid haemorrhage, peripheral arterial disease, and abdominal aortic aneurysm. $\textbf{Results }$ 114 859 individuals received an incident cardiovascular diagnosis during follow-up. Non-drinking was associated with an increased risk of unstable angina (hazard ratio 1.33, 95% confidence interval 1.21 to 1.45), myocardial infarction (1.32, 1.24 to1.41), unheralded coronary death (1.56, 1.38 to 1.76), heart failure (1.24, 1.11 to 1.38), ischaemic stroke (1.12, 1.01 to 1.24), peripheral arterial disease (1.22, 1.13 to 1.32), and abdominal aortic aneurysm (1.32, 1.17 to 1.49) compared with moderate drinking (consumption within contemporaneous UK weekly/daily guidelines of 21/3 and 14/2 units for men and women, respectively). Heavy drinking (exceeding guidelines) conferred an increased risk of presenting with unheralded coronary death (1.21, 1.08 to 1.35), heart failure (1.22, 1.08 to 1.37), cardiac arrest (1.50, 1.26 to 1.77), transient ischaemic attack (1.11, 1.02 to 1.37), ischaemic stroke (1.33, 1.09 to 1.63), intracerebral haemorrhage (1.37, 1.16 to 1.62), and peripheral arterial disease (1.35; 1.23 to 1.48), but a lower risk of myocardial infarction (0.88, 0.79 to 1.00) or stable angina (0.93, 0.86 to 1.00). $\textbf{Conclusions }$ Heterogeneous associations exist between level of alcohol consumption and the initial presentation of cardiovascular diseases. This has implications for counselling patients, public health communication, and clinical research, suggesting a more nuanced approach to the role of alcohol in prevention of cardiovascular disease is necessary. $\textbf{Registration }$ clinicaltrails.gov (NCT01864031).
Article
Full-text available
Objectives To investigate the association between alcohol consumption and cardiovascular disease at higher resolution by examining the initial lifetime presentation of 12 cardiac, cerebrovascular, abdominal, or peripheral vascular diseases among five categories of consumption. Design Population based cohort study of linked electronic health records covering primary care, hospital admissions, and mortality in 1997-2010 (median follow-up six years). Setting CALIBER (ClinicAl research using LInked Bespoke studies and Electronic health Records). Participants 1 937 360 adults (51% women), aged ≥30 who were free from cardiovascular disease at baseline. Main outcome measures 12 common symptomatic manifestations of cardiovascular disease, including chronic stable angina, unstable angina, acute myocardial infarction, unheralded coronary heart disease death, heart failure, sudden coronary death/cardiac arrest, transient ischaemic attack, ischaemic stroke, intracerebral and subarachnoid haemorrhage, peripheral arterial disease, and abdominal aortic aneurysm. Results 114 859 individuals received an incident cardiovascular diagnosis during follow-up. Non-drinking was associated with an increased risk of unstable angina (hazard ratio 1.33, 95% confidence interval 1.21 to 1.45), myocardial infarction (1.32, 1.24 to1.41), unheralded coronary death (1.56, 1.38 to 1.76), heart failure (1.24, 1.11 to 1.38), ischaemic stroke (1.12, 1.01 to 1.24), peripheral arterial disease (1.22, 1.13 to 1.32), and abdominal aortic aneurysm (1.32, 1.17 to 1.49) compared with moderate drinking (consumption within contemporaneous UK weekly/daily guidelines of 21/3 and 14/2 units for men and women, respectively). Heavy drinking (exceeding guidelines) conferred an increased risk of presenting with unheralded coronary death (1.21, 1.08 to 1.35), heart failure (1.22, 1.08 to 1.37), cardiac arrest (1.50, 1.26 to 1.77), transient ischaemic attack (1.11, 1.02 to 1.37), ischaemic stroke (1.33, 1.09 to 1.63), intracerebral haemorrhage (1.37, 1.16 to 1.62), and peripheral arterial disease (1.35; 1.23 to 1.48), but a lower risk of myocardial infarction (0.88, 0.79 to 1.00) or stable angina (0.93, 0.86 to 1.00). Conclusions Heterogeneous associations exist between level of alcohol consumption and the initial presentation of cardiovascular diseases. This has implications for counselling patients, public health communication, and clinical research, suggesting a more nuanced approach to the role of alcohol in prevention of cardiovascular disease is necessary. Registration clinicaltrails.gov (NCT01864031).
Article
Background: Both sodium reduction and the DASH (Dietary Approaches to Stop Hypertension) diet, a diet rich in fruits, vegetables, and low-fat dairy products, and reduced in saturated fat and cholesterol, lower blood pressure. The separate and combined effects of these dietary interventions by baseline blood pressure (BP) has not been reported. Objectives: The authors compared the effects of low versus high sodium, DASH versus control, and both (low sodium-DASH vs. high sodium-control diets) on systolic BP (SBP) by baseline BP. Methods: In the DASH-Sodium (Dietary Patterns, Sodium Intake and Blood Pressure) trial, adults with pre- or stage 1 hypertension and not using antihypertensive medications, were randomized to either DASH or a control diet. On either diet, participants were fed each of 3 sodium levels (50, 100, and 150 mmol/day at 2,100 kcal) in random order over 4 weeks separated by 5-day breaks. Strata of baseline SBP were <130, 130 to 139, 140 to 149, and ≥150 mm Hg. Results: Of 412 participants, 57% were women, and 57% were black; mean age was 48 years, and mean SBP/diastolic BP was 135/86 mm Hg. In the context of the control diet, reducing sodium (from high to low) was associated with mean SBP differences of -3.20, -8.56, -8.99, and -7.04 mm Hg across the respective baseline SBP strata listed (p for trend = 0.004). In the context of high sodium, consuming the DASH compared with the control diet was associated with mean SBP differences of -4.5, -4.3, -4.7, and -10.6 mm Hg, respectively (p for trend = 0.66). The combined effects of the low sodium-DASH diet versus the high sodium-control diet on SBP were -5.3, -7.5, -9.7, and -20.8 mm Hg, respectively (p for trend < 0.001). Conclusions: The combination of reduced sodium intake and the DASH diet lowered SBP throughout the range of pre- and stage 1 hypertension, with progressively greater reductions at higher levels of baseline SBP. SBP reductions in adults with the highest levels of SBP (≥150 mm Hg) were striking and reinforce the importance of both sodium reduction and the DASH diet in this high-risk group. Further research is needed to determine the effects of these interventions among adults with SBP ≥160 mm Hg. (Dietary Patterns, Sodium Intake and Blood Pressure [DASH-Sodium]; NCT00000608).
Article
Background: Hypertension is common in China and its prevalence is rising, yet it remains inadequately controlled. Few studies have the capacity to characterise the epidemiology and management of hypertension across many heterogeneous subgroups. We did a study of the prevalence, awareness, treatment, and control of hypertension in China and assessed their variations across many subpopulations. Methods: We made use of data generated in the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) Million Persons Project from Sept 15, 2014, to June 20, 2017, a population-based screening project that enrolled around 1·7 million community-dwelling adults aged 35-75 years from all 31 provinces in mainland China. In this population, we defined hypertension as systolic blood pressure of at least 140 mm Hg, or diastolic blood pressure of at least 90 mm Hg, or self-reported antihypertensive medication use in the previous 2 weeks. Hypertension awareness, treatment, and control were defined, respectively, among hypertensive adults as a self-reported diagnosis of hypertension, current use of antihypertensive medication, and blood pressure of less than 140/90 mm Hg. We assessed awareness, treatment, and control in 264 475 population subgroups-defined a priori by all possible combinations of 11 demographic and clinical factors (age [35-44, 45-54, 55-64, and 65-75 years], sex [men and women], geographical region [western, central, and eastern China], urbanity [urban vs rural], ethnic origin [Han and non-Han], occupation [farmer and non-farmer], annual household income [< ¥10 000, ¥10 000-50 000, and ≥¥50 000], education [primary school and below, middle school, high school, and college and above], previous cardiovascular events [yes or no], current smoker [yes or no], and diabetes [yes or no]), and their associations with individual and primary health-care site characteristics, using mixed models. Findings: The sample contained 1 738 886 participants with a mean age of 55·6 years (SD 9·7), 59·5% of whom were women. 44·7% (95% CI 44·6-44·8) of the sample had hypertension, of whom 44·7% (44·6-44·8) were aware of their diagnosis, 30·1% (30·0-30·2) were taking prescribed antihypertensive medications, and 7·2% (7·1-7·2) had achieved control. The age-standardised and sex-standardised rates of hypertension prevalence, awareness, treatment, and control were 37·2% (37·1-37·3), 36·0% (35·8-36·2), 22·9% (22·7-23·0), and 5·7% (5·6-5·7), respectively. The most commonly used medication class was calcium-channel blockers (55·2%, 55·0-55·4). Among individuals whose hypertension was treated but not controlled, 81·5% (81·3-81·6) were using only one medication. The proportion of participants who were aware of their hypertension and were receiving treatment varied significantly across subpopulations; lower likelihoods of awareness and treatment were associated with male sex, younger age, lower income, and an absence of previous cardiovascular events, diabetes, obesity, or alcohol use (all p<0·01). By contrast, control rate was universally low across all subgroups (<30·0%). Interpretation: Among Chinese adults aged 35-75 years, nearly half have hypertension, fewer than a third are being treated, and fewer than one in twelve are in control of their blood pressure. The low number of people in control is ubiquitous in all subgroups of the Chinese population and warrants broad-based, global strategy, such as greater efforts in prevention, as well as better screening and more effective and affordable treatment. Funding: Ministry of Finance and National Health and Family Planning Commission, China.